The Vakilkaro Brief: The “Nose of a Worm” Patent: Rejection of Bio-Diagnostic IP

Nature’s Olfactory Marvel vs. Patent Law. Imagine a world where a tiny roundworm can sniff out cancer from a single drop of urine with 100% accuracy. This isn't science fiction—it's the "N-NOSE" technology. However, a recent landmark ruling by the Delhi High Court has sent shockwaves through the biotech industry by refusing patent protection for this "worm-based" diagnostic. We dive into the legal tug-of-war between breakthrough innovation and the statutory bar on medical diagnostic methods.

Key Takeaways

• However, a recent landmark ruling by the Delhi High Court has sent shockwaves through the biotech industry by refusing patent protection for this "worm-based" diagnostic.
• The "Nose of a Worm" Patent: Rejection of Bio-Diagnostic IP From the petri dish to the High Court benches.
• Assistant Controller of Patents and Designs, the interpretation of Section 3(i), and the fine line between "screening" and "diagnosis." The Update: In January 2026, the Delhi High Court upheld the Indian Patent Office’s rejection of a patent application by the Japanese firm Hirotsu Bio Science Inc.
• The Action: Startups in the bio-diagnostic and AI-healthcare space must pivot their patent strategies.
• The Argument: The appellant argued that diagnosis requires a "doctor's clinical judgment," and since a worm/machine did the work, it wasn't a "diagnostic method." The Ruling: The Court held that it is immaterial who performs the method.

The "Nose of a Worm" Patent: Rejection of Bio-Diagnostic IP

From the petri dish to the High Court benches. We provide a comprehensive guide on the January 2026 judgment in Hirotsu Bio Science Inc. v. Assistant Controller of Patents and Designs, the interpretation of Section 3(i), and the fine line between "screening" and "diagnosis."

• The Update: In January 2026, the Delhi High Court upheld the Indian Patent Office’s rejection of a patent application by the Japanese firm Hirotsu Bio Science Inc. The invention used the nematode Caenorhabditis elegans —a tiny worm with a highly sophisticated sense of smell—to detect cancer. The worms exhibit "chemotaxis," moving toward urine samples of cancer patients and away from healthy ones. While revolutionary and non-invasive, Justice Tejas Karia ruled that the method constitutes a "diagnostic process," which is strictly non-patentable under Section 3(i) of the Patents Act, 1970.
• The Impact: This ruling clarifies a massive gray area in Indian IP: In Vitro vs. In Vivo. The appellant argued that because the test happened in a lab (in vitro) and not on a human body, it should be patentable. The Court disagreed, stating that Section 3(i) makes no such distinction. If a process is capable of identifying a disease—even if it's just a preliminary screening—it falls under the diagnostic bar. For the biotech industry, this means that while the "device" or "kit" might be patentable, the "method of testing" remains in the public domain to ensure healthcare stays accessible.
• The Action: Startups in the bio-diagnostic and AI-healthcare space must pivot their patent strategies. If your innovation identifies a disease, don't just claim the "method of detection." Focus your patent claims on the hardware, the specific chemical reagents, or the unique software algorithms used to analyze the data. The "process of diagnosis" is a legal dead-end in India, but the "tools of diagnosis" are still fair game.

1. The Science: How C. elegans "Sniffs" Cancer

The nematode C. elegans has about 1,200 odorant receptors (compared to a human's ~400).

• Chemotaxis: The invention relied on the worm's natural instinct to move toward specific volatile organic compounds (VOCs) found in the urine of cancer patients.
• The Claim: Hirotsu claimed their "N-NOSE" method could detect 15 types of cancer (including early-stage gastric and pancreatic) with extreme accuracy.

2. The Legal Wall: Decoding Section 3(i)

Under the Indian Patents Act, certain things are "not inventions."

Section 3(i): Any process for the medicinal, surgical, curative, prophylactic, diagnostic, therapeutic or other treatment of human beings... is not patentable.

The core intent is public policy: No one should own a monopoly on the "way" a disease is identified or treated.

3. The "In Vitro" Trap: Why Lab-Only Tests Fail

Hirotsu argued that their test was "preliminary screening" and happened outside the body.

• The Court's View: A diagnostic is a diagnostic. Whether it happens inside a patient or in a test tube, if the end result is the identification of a disease, it cannot be patented.
• The Distinction: Unlike some Western jurisdictions (like the EPO) that allow certain in vitro diagnostic patents, India maintains a "Strict Bar."

4. The "Immaterial Performer" Rule

A fascinating aspect of this 2026 judgment is the "Who" factor.

• The Argument: The appellant argued that diagnosis requires a "doctor's clinical judgment," and since a worm/machine did the work, it wasn't a "diagnostic method."
• The Ruling: The Court held that it is immaterial who performs the method. If the law allowed patents just because a machine or a worm did the "diagnosing," the entire purpose of Section 3(i) would be defeated by automation.

The "Good, Bad, and Ugly" of the Hirotsu Ruling

The Good The Bad The Ugly

Public Interest: Keeps life-saving diagnostic methods affordable and free from high royalty "trolls." Investment Choke: May discourage global biotech firms from launching R&D centers in India due to lack of method protection. Strategic Dead-end: Companies that spent millions on "method-only" IP find their Indian portfolios effectively worthless.

5. Can Anything in Bio-Diagnostics be Patented?

Yes, but you have to be surgical with your claims:

• The Kit: A physical device containing specific sensors or chambers.
• The Composition: A novel chemical reagent or a genetically modified organism (if it doesn't fall under Section 3(j)).
• The AI/Software: The algorithm that processes the "smell data" (provided it shows a technical contribution under Section 3(k)).

6. Checklist: How to Draft Bio-Diagnostic Patents in India

If you are developing a new testing method:

• Shift Focus to Products: Draft claims around the apparatus or system used for the test.
• Avoid "Identifying Disease" Language: Frame the result as "providing data for analysis" rather than "diagnosing a condition."
• Prove Technical Effect: If using AI, show how the code solves a technical problem in data processing, not just a medical one.
• Analyze Precedents: Look at the Chinese University of Hong Kong and Natera Inc. cases for successful (and unsuccessful) claim structures.

Conclusion and What Should You Do Now?

The "Nose of a Worm" case is a stark reminder that in India, Innovation ≠ Patentability. While the science is brilliant, the law prioritizes the accessibility of diagnostic methods over the exclusivity of the inventor. This 2026 ruling sets a high bar for the burgeoning health-tech sector.

Strategy is Key:

• Audit Your Portfolio: If your patents rely solely on "method" claims, consult an attorney to see if they can be amended to "system" or "apparatus" claims.
• Think Hardware: The future of diagnostic IP in India lies in the hardware that facilitates the test, not the logic of the test itself.
• Follow the IPD: The Intellectual Property Division (IPD) of the High Courts is rewriting the rules of biotech IP—staying updated is no longer optional.

In the race to detect disease, the law ensures that the finish line remains open to all. Stay tuned as we bring you the latest developments from the Hon’ble Supreme Court and High Courts of India. Vakilkaro offers comprehensive legal services in Intellectual Property Rights, including patent registration, trademark, and copyright registration. We also assist with business registration and licensing like LLP, OPC, and Private Limited Company registration, ensuring seamless compliance and regulatory support for businesses.

Official External Resources

Use these primary/official sources to verify rules, forms, fees, timelines and regulatory updates before publication.

• IP India - Patents, Designs, Trade Marks & Copyright
• Income Tax Department e-Filing Portal
• eCourts Services